BRIEF published on 09/16/2024 at 11:22, 2 years ago Banque Palatine introduces Palatine Avenir 2030, a risky debt security Investment Stock Market Palatine Bank Debt Security Capital Risk
PRESS RELEASE published on 09/16/2024 at 11:17, 2 years ago Informations privilégiées / Autres communiqués La Banque Palatine lance Palatine Avenir 2030, un titre de créance à risque. Détails financiers et modalités de souscription inclus Souscription Banque Palatine Titre De Créance Palatine Avenir 2030 Risque
BRIEF published on 09/12/2024 at 10:50, 2 years ago Disponibilité des Final Terms de l'émission série 579 tranche 1 par la BFCM Investisseurs Final Terms Crédit Mutuel BFCM Émission Série 579
BRIEF published on 09/12/2024 at 10:50, 2 years ago Availability of the Final Terms of the 579 series issue tranche 1 by BFCM Investors Final Terms Crédit Mutuel BFCM Series 579 Broadcast
PRESS RELEASE published on 09/12/2024 at 10:45, 2 years ago BFCM Communiqué de mise à disposition des Final Terms de l’émission série 579 tranche 1 La Banque Fédérative du Crédit Mutuel communique les modalités de disponibilité des Final Terms de l’émission séries 579 tranche 1. Les documents sont accessibles sur le site de l’émetteur Final Terms Modalités Émission Document BFCM
BRIEF published on 09/12/2024 at 08:42, 2 years ago Sanofi, RadioMedix, and Orano Med Announce Exclusive Licensing Agreement for Radioligand Therapy Sanofi RadioMedix Orano Med AlphaMedix Neuroendocrine Tumors
BRIEF published on 09/12/2024 at 08:42, 2 years ago Sanofi, RadioMedix et Orano Med annoncent un accord de licence exclusif pour la thérapie par radioligand Sanofi Orano Med AlphaMedix Radio Médix Tumeurs Neuroendocrines
PRESS RELEASE published on 09/12/2024 at 08:37, 2 years ago Inside Information / Other news releases Sanofi, RadioMedix, and Orano Med announce licensing agreement on next-generation radioligand medicine for rare cancers Sanofi RadioMedix Orano Med Radioligand Medicine Rare Cancers
PRESS RELEASE published on 09/12/2024 at 08:37, 2 years ago Informations privilégiées / Autres communiqués Accord de licence entre Sanofi, RadioMedix et Orano Med pour le développement de radiothérapies internes vectorisées contre les cancers rares. Collaboration innovante dans le domaine de l'oncologie Radiotherapies Sanofi Accord De Licence RadioMedix Orano Med
Published on 09/26/2026 at 01:00, 2 days 3 hours ago Findev Inc. Provides Update on Victoria Park Loan Exposure and Expected Accounting Impairment
Published on 09/25/2026 at 22:15, 2 days 6 hours ago Rocky Shore Gold Closes First Tranche of Non-Brokered Private Placement
Published on 09/25/2026 at 17:30, 2 days 11 hours ago Goldcliff Announces Unit and Flow Through "LIFE" Offerings
Published on 09/25/2026 at 15:00, 2 days 13 hours ago HM Exploration Provides Program Update for the Lewis Pilley's Project
Published on 09/27/2026 at 17:05, 11 hours 24 minutes ago Saudi Tourism Authority Concludes Monaco Yacht Show 2026 with Major Milestones for Saudi Red Sea Yachting
Published on 09/26/2026 at 15:30, 1 day 13 hours ago QUORRA X5 fait ses débuts mondiaux à REHACARE International 2026 en Allemagne
Published on 09/26/2026 at 15:30, 1 day 13 hours ago QUORRA X5 Makes Its Global Debut at REHACARE International 2026 in Germany
Published on 09/26/2026 at 15:15, 1 day 13 hours ago Timur Turlov Elected FIDE President, Becomes First Kazakh to Lead World Chess
Published on 09/26/2026 at 07:45, 1 day 20 hours ago Green SM Begins Pilot Operations In The Netherlands, Further Expanding Its Presence In Europe
Published on 09/25/2026 at 17:45, 2 days 10 hours ago COGRA : ASSEMBLÉE GÉNÉRALE MIXTE DU 16 OCTOBRE 2026 / MISE À DISPOSITION DU RAPPORT FINANCIER ANNUEL 2025/2026
Published on 09/25/2026 at 17:40, 2 days 10 hours ago Availability of the 2026 half-year financial report
